Mercury and DMPS Usage
[AMA Policy on Alternative Medicine] [XXVI International Congress] [Book Review] [Main]


Mercury and DMPS Usage

It is important to be involved in this project if
you are using or are thinking about using DMPS

Would you consider using EDTA Chelation Therapy in your office without learning how to properly dose a patient, the proper procedures, laboratory tests required and adjunctive care necessary to make the treatment successful? Of course not!

Should DMPS be treated any differently?

DMPS is not an FDA approved chemical, however, it is considered a custom compound. This puts this molecule in a very gray area. Patients who present mercury toxicity or sensitivity are understandably the most difficult and complicated patients in your practice.

The symptoms of mercury poisoning can include: 1. tremor in fine voluntary muscle movement, 2. depression, 3. fatigue, 4. moodiness, 5. inability to concentrate, 6. birth defects, and 7. nephritis. The Environmental Protection Agency (EPA) has set a "safe" exposure level to mercury vapor at 10 nmol/ day. The Federal Government now admits that the average US adult receives 20 nmol/day, just from their amalgam fillings!

Because of these factors, it was felt that proper procedures and a specific protocol for the use of DMPS must be devised and properly tested. At GLACM it was decided that an IRB study and protocol should be submitted to properly study the safety and effectiveness of a treatment protocol to detoxify the mercury toxic/sensitive patient.

We are pleased to announce that in February of 1995, the Board approved the study to go multi-center.

The writings, protocols, lectures and computer collection. data have been put together without funding from outside sources; therefore, the results of this study will have no one trying to dictate its outcome.

This offers you, the clinician, the chance to take part in a possible history changing study. It will also teach you how to treat these very ill and complicated patients safely.

Currently, researchers from 26 states and 3 foreign countries have been trained. We invite you to join us in this project. The next seminar is September 18th & 19th, 1996 at the Milwaukee Hilton just prior to the GLACM meeting. The cost is only $695 (preregistered and paid) or $770 at the door for physicians and dentists ($350 for staff).

For reservations, call: (360) 253-4445
Paula R. Bickle, RDH, Ph.D., Principal Investigator


[AMA Policy on Alternative Medicine] [XXVI International Congress] [Book Review] [Main]